Lipid-lowering therapy in membranous nephropathy
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 56, S110-S112
- https://doi.org/10.1046/j.1523-1755.1999.07127.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.Journal of Clinical Investigation, 1997
- Do Glomerular Atherosclerosis and Lipid-Mediated Tubulo-lnterstitial Disease Cause Progressive Renal Failure in Man?Blood Purification, 1996
- A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathyKidney International, 1995
- Metabolism of low density lipoproteins in nephrotic dyslipidemia: Comparison of hypercholesterolemia alone and combined hyperlipidemiaKidney International, 1995
- Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.Journal of Clinical Investigation, 1994
- Lipids and the kidneyKidney International, 1994
- Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritisKidney International, 1992
- Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.Journal of Clinical Investigation, 1990
- Lipid-Lowering Agents in Proteinuric DiseasesAmerican Journal of Nephrology, 1990
- Probucol inhibits oxidative modification of low density lipoprotein.Journal of Clinical Investigation, 1986